Heroin

Valiant Behavioural Health Celebrates 5 Years

Retrieved on: 
Wednesday, August 30, 2023

OTTAWA, ON, Aug. 30, 2023 /PRNewswire/ -- October 10th marks five years since the opening of Valiant Behavioural Health, an addiction and mental health treatment program based in Ottawa, Ontario. Since opening its doors five years ago, Valiant has been on a mission to make meaningful and lasting changes in the lives of individuals and families in Ottawa by providing unparalleled care to those seeking treatment for mental health and substance use.

Key Points: 
  • OTTAWA, ON, Aug. 30, 2023 /PRNewswire/ -- October 10th marks five years since the opening of Valiant Behavioural Health, an addiction and mental health treatment program based in Ottawa, Ontario.
  • Valiant Behavioural Health approach to treatment has been a successful combination of evidence-based care, a client-centered atmosphere and holistic practices.
  • "At Valiant, we take a comprehensive, holistic approach to substance use and mental health treatment," says Royce Dockrill, Chief Executive Officer of Valiant Behavioural Health.
  • Valiant Behavioural Health is part of the Valiant Recovery brand of treatment centers, one of Canada's leading addiction and mental health treatment providers .

Pinnacle Treatment Centers to host Grand Opening celebration for Winchester Treatment Services

Retrieved on: 
Monday, August 28, 2023

One of Pinnacle’s 8 opioid treatment programs (OTP) in the state , Winchester Treatment Services provides medication-assisted treatment (MAT), particularly methadone and suboxone, coupled with various methods of counseling and behavioral therapies at the facility.

Key Points: 
  • One of Pinnacle’s 8 opioid treatment programs (OTP) in the state , Winchester Treatment Services provides medication-assisted treatment (MAT), particularly methadone and suboxone, coupled with various methods of counseling and behavioral therapies at the facility.
  • MAT is the gold standard of care for opioid addiction.
  • The FDA-approved medicines work to curb withdrawal symptoms from heroin and pain pill addiction, prevent relapse, and help ease the physical discomfort that accompanies opioid recovery.
  • Individuals needing addiction treatment can call (859) 287-1098 for a free, confidential assessment.

Tris Pharma Awarded Five-Year Grant of Up to $16.6M From the NIH's National Institute on Drug Abuse to Advance Cebranopadol for the Treatment of Opioid Use Disorder

Retrieved on: 
Monday, August 28, 2023

Through the Helping to End Addiction Long-term® Initiative (NIH HEAL Initiative®), NIH has awarded grants to fund the optimization of new therapies to prevent and treat opioid use disorder (OUD).

Key Points: 
  • Through the Helping to End Addiction Long-term® Initiative (NIH HEAL Initiative®), NIH has awarded grants to fund the optimization of new therapies to prevent and treat opioid use disorder (OUD).
  • Cebranopadol is an investigational, dual nociception/orphanin FQ peptide (NOP) receptor and µ-opioid peptide (MOP) receptor agonist.
  • Further, cebranopadol has demonstrated reduced cocaine and heroin self-administration and drug-seeking behaviors, reinforcing its potential as an effective treatment for OUD.
  • The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.

The Band's Robbie Robertson leaves behind a legacy of rich, worldly music

Retrieved on: 
Wednesday, August 23, 2023

When Robbie Robertson died on Aug. 9, his death was well-covered by the media, from mainstream news outlets to a wide variety of music magazines, and across the blogosphere.

Key Points: 
  • When Robbie Robertson died on Aug. 9, his death was well-covered by the media, from mainstream news outlets to a wide variety of music magazines, and across the blogosphere.
  • Robertson died at age 80 after a long illness.

Canadian musician, American music

    • Even Trudeau’s comments seem rather generic and half-hearted compared to his effusive praise for Lightfoot as one of Canada’s “greatest performers” who “captured the Canadian spirit.” To do the same for Robertson — who made his name in the American music scene — would be ridiculous.
    • And both enjoyed long careers that included recognition from the Canadian Songwriters Hall of Fame.
    • And unlike Lightfoot, Robertson couldn’t read or write music.

Touring with Dylan

    • Robertson’s stint as part of Bob Dylan’s band through the mid-1960s, as Dylan toured the world with a new, electrified sound, was surely part of this cosmopolitanism.
    • After leaving Dylan, this supporting band would become The Band, with Robertson as its chief songwriter.
    • However, Robertson would effectively leave the group in 1976: he was tired of touring and was reluctant to work with the other members due in part to their heroin addictions.

Composing for film

    • Of course, Robertson also differed significantly from Lightfoot in that he had a long and successful career as a composer for films.
    • Robertson was credited in almost 20 Scorsese films, if you include Robertson’s performance in The Last Waltz, the 1976 film Scorsese made of The Band’s final concert with its original line-up.

A paradoxical figure

    • Robertson, ultimately, was something of a paradoxical figure.
    • Robertson also had a different connection to place than his fellow Canadian Lightfoot, having been born on a reserve to a Mohawk and Cayuga mother.
    • Robertson favoured cultural blending and border-crossing, ignoring genre boundaries and creating something new and engaging out of a patchwork of possibilities.

Why imprisoning repeat shoplifters rarely breaks the cycle of offending – and what may work better

Retrieved on: 
Friday, August 11, 2023

And recently, government ministers have been talking tough about repeat shoplifting, including the possibility of introducing new laws which would see prolific shoplifters imprisoned.

Key Points: 
  • And recently, government ministers have been talking tough about repeat shoplifting, including the possibility of introducing new laws which would see prolific shoplifters imprisoned.
  • This has all been against a backdrop of concern about a rise in shoplifting across the UK.
  • But there are some serious practical problems with any such measures and questions remain over whether such a policy could break the cycle of offending.
  • Rolled out over the past few years, IOM is a novel criminal justice approach that is designed to break the cycle of re-offending.

The problem with prison

    • The UK’s prison estate is running out of capacity for adult males.
    • Figures released in August 2023 show a total of just 980 available prison places.
    • These people arrive in prison as addicts and likely leave as addicts and so will continue shoplifting.

Integrated offender management

    • Here, the police take a “carrot and stick” approach to the management of offenders.
    • Plain-clothed officers, deployed as police offender managers, gather intelligence and monitor people for signs of re-offending.
    • But IOM can only fully operate when people are able to access the relevant support services in the community.
    • IOM may be a better and more cost effective way to deal with the pressing issue of repeated shoplifting.

Neuragenex Expands to Open New Illinois Location, Giving More People Access to its Innovative Approach to Chronic Pain Management

Retrieved on: 
Tuesday, August 8, 2023

With its groundbreaking approach to chronic pain management that is drug-free and non-invasive, Neuragenex is dedicated to becoming the largest and fastest growing chronic pain management practice in the United States.

Key Points: 
  • With its groundbreaking approach to chronic pain management that is drug-free and non-invasive, Neuragenex is dedicated to becoming the largest and fastest growing chronic pain management practice in the United States.
  • Specializing in non-pharmaceutical and non-invasive pain management treatments, Neuragenex recognizes that traditional pain management approaches often rely on medications, surgeries, or therapies with limited efficacy.
  • Patients who have experienced Neuragenex's innovative approach to chronic pain management have reported remarkable success and transformative outcomes.
  • Committed to pushing the boundaries of pain management, Neuragenex continuously aims to provide relief and improve the lives of individuals suffering from persistent pain.

Neuragenex Expands to Open New Utah Location, Giving More People Access to its Innovative Approach to Chronic Pain Management

Retrieved on: 
Tuesday, August 8, 2023

With its groundbreaking approach to chronic pain management that is drug-free and non-invasive, Neuragenex is dedicated to becoming the largest and fastest growing chronic pain management practice in the United States.

Key Points: 
  • With its groundbreaking approach to chronic pain management that is drug-free and non-invasive, Neuragenex is dedicated to becoming the largest and fastest growing chronic pain management practice in the United States.
  • Despite this seemingly common goal, what differentiates Neuragenex however is their commitment to developing innovative solutions that go beyond conventional pain management approaches.
  • Specializing in non-pharmaceutical and non-invasive pain management treatments, Neuragenex recognizes that traditional pain management approaches often rely on medications, surgeries, or therapies with limited efficacy.
  • Patients who have experienced Neuragenex's innovative approach to chronic pain management have reported remarkable success and transformative outcomes.

TAKING ON THE OPIOID OVERDOSE EPIDEMIC IN NEW JERSEY

Retrieved on: 
Thursday, August 3, 2023

HACKENSACK, N.J., Aug. 3, 2023 /PRNewswire/ -- HIKMA Pharmaceuticals, Hackensack Meridian Health (HMH) and non-profit Dispensary of Hope are teaming up to pilot a Take-Home Naloxone Program to stem the tide of opioid overdose fatalities by delivering Kloxxado® (naloxone HCl) Nasal Spray 8 mg free of charge to patients at high risk of an opioid overdose. Kloxxado® contains naloxone, an opioid antagonist that can save the lives of patients who have overdosed with an opioid.1 All three organizations share a vision of providing affordable medication access, with a particular focus on communities and individuals who are most vulnerable.

Key Points: 
  • Hackensack Meridian Health, HIKMA Pharmaceuticals and Dispensary of Hope join forces to save lives from opioid overdose.
  • Opioid overdoses are preventable and tragic.
  • 2022, "Responding to the opioid crisis in North America and beyond: recommendations of the Stanford–Lancet Commission," The Lancet,  399:10324, p555-604
    3 Opioid Basics: Understanding the Opioid Epidemic.
  • CDC, https://www.cdc.gov/stopoverdose/fentanyl/index.html , Accessed 2022 1006
    6 Abdelal et al., 2022, "Real-world study of multiple naloxone administration for opioid overdose reversal among bystanders," Harm Reduction Journal, 19:49.

Dr. Vince Clinical Research Joins the Fight Against the Fentanyl Crisis, Announces Screening of First Subject for Cessation Therapeutics’ Overdose Prevention Therapy in a First-In-Human Trial

Retrieved on: 
Wednesday, August 2, 2023

CSX-1004 is a human monoclonal antibody infusion that is being developed for the prevention of fentanyl overdose.

Key Points: 
  • CSX-1004 is a human monoclonal antibody infusion that is being developed for the prevention of fentanyl overdose.
  • The study is being conducted at DVCR’s world-class clinical pharmacology unit located in Overland Park, Kansas .
  • CSX-1004 potently binds to fentanyl and structurally related synthetic opioids, blocking them from entering the brain.
  • Cessation’s Chief Scientific Officer Andy Barrett, Ph.D., stated, “We are thrilled to partner with Dr. Vince Clinical Research on this critical First-In-Human study.

Opioids and cocaine are a deadly combination – and 'polydrug' deaths are rising

Retrieved on: 
Monday, July 31, 2023

Drug-related deaths associated with stimulants, such as cocaine, methamphetamine, amphetamine and methylphenidate, doubled between 2011 and 2021.

Key Points: 
  • Drug-related deaths associated with stimulants, such as cocaine, methamphetamine, amphetamine and methylphenidate, doubled between 2011 and 2021.
  • And deaths associated with using both stimulants and opioids, such as heroin, morphine, fentanyl and methadone, increased by about sevenfold over the same period.
  • Cocaine and methamphetamine are stimulant drugs, whereas opioids, such as heroin and methadone, are depressants.
  • Taken together, it can be seen that there may be a worldwide increase in polydrug-related deaths and in particular those involving both stimulants and opioids.